Skip to content

Hyperglycaemia in cats: medicines most often reported

2,885 FDA reports in cats mention hyperglycaemia. These are the medicines named most often in those reports.

Bexagliflozin (Bexacat)

911 22% of its reports

351 9.4% of its reports

Cefovecin (Convenia)

347 4.0% of its reports

Maropitant (Cerenia)

239 6.2% of its reports

Selamectin (Revolution)

149 0.7% of its reports

Frunevetmab (Solensia)

146 1.8% of its reports

138 2.5% of its reports

Methylprednisolone

131 8.2% of its reports

Meloxicam (Metacam)

130 3.6% of its reports

Robenacoxib (Onsior)

125 3.8% of its reports

102 3.9% of its reports

Amoxicillin + Clavulanate (Clavamox)

92 3.9% of its reports

Cyclosporine (Atopica)

89 2.9% of its reports

86 4.4% of its reports

Eprinomectin + Esafoxolaner + Praziquantel (NexGard Combo)

86 2.6% of its reports

Mirtazapine (Mirataz)

82 4.4% of its reports

Fluralaner (Bravecto)

81 0.8% of its reports

Feline Core Vaccine

75 4.8% of its reports

71 9.3% of its reports

69 5.6% of its reports

Sarolaner + Selamectin (Revolution Plus)

61 0.7% of its reports

60 2.7% of its reports

55 2.7% of its reports

Capromorelin (Entyce)

52 6.3% of its reports

Enrofloxacin (Baytril)

49 3.1% of its reports

Emodepside + Praziquantel (Profender)

49 0.9% of its reports

48 2.7% of its reports

Dexmedetomidine (Dexdomitor)

48 1.8% of its reports

Spinosad (Comfortis)

47 0.4% of its reports

46 1.4% of its reports

Dexamethasone + Neomycin + Thiabendazole

40 5.0% of its reports

39 13% of its reports

Imidacloprid + Moxidectin (Advantage Multi)

37 0.5% of its reports

34 2.9% of its reports

31 7.6% of its reports

Feline Leukemia Vaccine

31 3.9% of its reports

Velagliflozin (Senvelgo)

31 0.6% of its reports

29 3.3% of its reports

Fluralaner + Moxidectin (Bravecto Plus)

29 0.9% of its reports

28 3.7% of its reports

27 12% of its reports

Carprofen (Rimadyl)

26 1.5% of its reports

26 32% of its reports

25 6.4% of its reports

Nitenpyram (Capstar)

25 0.3% of its reports

23 5.8% of its reports

21 3.7% of its reports

21 5.4% of its reports

Oclacitinib (Apoquel)

21 4.5% of its reports

20 4.2% of its reports

20 1.9% of its reports